Sandoz, Mylan Ask Justices To Affirm Teva Patent Invalidation
Generic-drug producers Sandoz Inc. and Mylan Inc. urged the U.S. Supreme Court on Monday to uphold a ruling that found several patents for Teva Pharmaceutical USA Inc.'s multiple sclerosis drug Copaxone...To view the full article, register now.
Already a subscriber? Click here to view full article